US Patent Issued to LGV1 on May 27 for "Methods for treating huntington's disease using a polynucleotide encoding a VTFT isoform of a BPIFB4 protein" (Italian Inventor)

ALEXANDRIA, Va., June 17 -- United States Patent no. 12,311,009, issued on May 27, was assigned to LGV1 S.R.L. (Naples, Italy).

"Methods for treating huntington's disease using a polynucleotide encoding a VTFT isoform of a BPIFB4 protein" was invented by Annibale Alessandro Puca (Naples, Italy).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates inter alia to a protein which is a VTFT isoform of a BPIFB4 protein or a functional fragment thereof for use in the treatment or prophylaxis of a condition selected from neuronal diseases and injuries, said diseases and injuries being associated with mitochondrial dysfunction and/or protein aggregation and/or ameliorated by CXCR4 activation."

The pat...